Hirakata, Japan

Tomoshi Ooya

This inventor holds 1 USPTO granted patent. Top assignee: The Green Cross Corporation. Active years: 1994.


% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 1994

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Tomoshi Ooya: Innovator in Human Serum Production

Introduction

Tomoshi Ooya is a notable inventor based in Hirakata, Japan. He has made significant contributions to the field of biotechnology, particularly in the production of human serum albumin. His innovative approach has the potential to enhance the efficiency of serum production, which is crucial for various medical applications.

Latest Patents

Ooya holds a patent for a method titled "Fatty acid supplemented medium for recombinant production of human serum." This invention involves cultivating a genetically engineered host that produces human serum albumin in a medium enriched with fatty acids containing 10 to 26 carbon atoms or their salts. The method significantly increases the production of human serum albumin, showcasing Ooya's expertise in biotechnological advancements. He has 1 patent to his name.

Career Highlights

Tomoshi Ooya is associated with The Green Cross Corporation, a company known for its focus on biopharmaceuticals and innovative healthcare solutions. His work at the company has been instrumental in advancing research and development in the field of human serum production.

Collaborations

Ooya has collaborated with notable colleagues, including Kaoru Kobayashi and Shinobu Kuwae. Their combined efforts contribute to the ongoing research and development initiatives within their organization.

Conclusion

Tomoshi Ooya's contributions to the field of biotechnology, particularly in the production of human serum albumin, highlight his innovative spirit and dedication to improving medical solutions. His work continues to influence advancements in biopharmaceuticals.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…